3 Aqua Feed and Bioscience Stocks With a Strong Future Roadmap: Avanti Feeds, Nitta Gelatin India and Titan Biotech
- October 7, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Avanti Feeds Rs 714.10, P/E 16.55. Nitta Gelatin Rs 1,668.10, P/E 14.81. Titan Biotech Rs 382.10, P/E 46.60. Closing prices of 6 Oct 2026.
Quick Answer
Aqua feed and bioscience stocks with the clearest long-term roadmaps today include Avanti Feeds in shrimp feed and shrimp exports, Nitta Gelatin India in gelatin and collagen peptides for food and pharma users and Titan Biotech in bioscience and speciality ingredient products. FY26 revenue growth was 8.9% at Avanti Feeds, 12.0% at Nitta Gelatin and 32.0% at Titan Biotech. P/E stands at 16.55 for Avanti Feeds (industry 34.46), 14.81 for Nitta Gelatin (industry 35.84) and 46.60 for Titan Biotech (industry 37.19). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.
Aqua feed and bioscience stocks give investors exposure to shrimp feed makers and speciality ingredient producers that sell to farms, food firms and pharma users. Results depend on shrimp prices, export demand and raw material costs, which is why margins matter as much as headline growth.
This list covers three feed and speciality ingredient stocks: Avanti Feeds for shrimp feed and shrimp exports, Nitta Gelatin India for gelatin and collagen peptides for food and pharma users and Titan Biotech for bioscience and speciality ingredient products. Every figure comes from the latest reported financials and the 6 October 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Aqua Feed and Bioscience Stocks?
Aqua feed and bioscience stocks are shares of companies that make shrimp feed, gelatin, collagen peptides and other biological ingredients. Results depend on aquaculture activity, export demand, input costs and operating margin, so steady customers and cost control separate the stronger names.
Aqua Feed and Bioscience Stocks at a Glance
The table compares size, valuation, return on equity and debt for the three aqua feed and bioscience stocks as of the 6 October 2026 close.
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE | Debt to Equity |
|---|---|---|---|---|---|---|
| Avanti Feeds | 714.10 | 9,726 | 16.55 | 34.46 | 18.44% | 0.00 |
| Nitta Gelatin India | 1,668.10 | 1,529 | 14.81 | 35.84 | 19.02% | 0.01 |
| Titan Biotech | 382.10 | 1,579 | 46.60 | 37.19 | 16.46% | 0.03 |
Among feed and speciality ingredient stocks, Avanti Feeds and Nitta Gelatin trade below the industry P/E, while Titan Biotech trades at a premium to the industry multiple.
Why Do Aqua Feed and Bioscience Stocks Have a Strong Roadmap in India?
Aqua feed and bioscience stocks have a strong roadmap in India because shrimp farming and exports are growing, demand for collagen and protein ingredients is rising and processors are adding value locally. Three drivers stand out.
- Aquaculture growth: More shrimp farming needs more feed.
- Health ingredients: Collagen and gelatin demand is rising in food and pharma.
- Export demand: Overseas buyers source shrimp and ingredients from India.
Avanti Feeds: Shrimp Feed and Exports Anchor the Roadmap
Avanti Feeds’ roadmap rests on shrimp feed and shrimp exports, with aquaculture growth and processing capacity supporting volumes.
Revenue grew from Rs 5,117.63 crore in FY22 to Rs 6,276.46 crore in FY26, a 22.6% rise, and FY26 revenue was 8.9% higher than FY25. FY26 net profit rose 17.8% to Rs 655.76 crore. Over four years, net profit rose from Rs 245.23 crore in FY22 to Rs 655.76 crore. In Q1 FY27, revenue grew 18.7% to Rs 1,965.58 crore, and net profit fell 37.4% to Rs 116.31 crore. Operating margin was 15.64% in FY26 and 9.03% in Q1 FY27 against 16.51% a year earlier.
Debt to equity is 0.00 and return on equity is 18.44%. FY26 operating cash flow was Rs 504.63 crore against capital expenditure of Rs 80.74 crore. Avanti Feeds paid a dividend of Rs 10 per share for FY26, a yield of 1.40%. At a P/E of 16.55 against an industry P/E of 34.46, the stock trades below its industry multiple.
What to watch: The Q1 FY27 operating margin of 9.03% was below the 16.51% of a year earlier, and FY26 revenue growth was only 8.9%. Q1 FY27 net profit was 37.4% lower than a year earlier.
Nitta Gelatin India: Gelatin and Collagen Peptides Drive the Pipeline
Nitta Gelatin’s roadmap rests on gelatin and collagen peptides for food and pharma users, with exports and health-focused products supporting growth.
Revenue grew from Rs 510.55 crore in FY22 to Rs 600.96 crore in FY26, a 17.7% rise, and FY26 revenue was 12.0% higher than FY25. FY26 net profit rose 15.9% to Rs 98.25 crore. Over four years, net profit rose from Rs 34.85 crore in FY22 to Rs 98.25 crore. In Q1 FY27, revenue grew 2.3% to Rs 144.54 crore, and net profit rose 31.6% to Rs 25.18 crore. Operating margin was 25.20% in FY26 and 27.00% in Q1 FY27 against 21.20% a year earlier.
Debt to equity is 0.01 and return on equity is 19.02%. FY26 operating cash flow was Rs 122.49 crore against capital expenditure of Rs 52.19 crore. Nitta Gelatin paid a dividend of Rs 7 per share for FY26, a yield of 0.42%. At a P/E of 14.81 against an industry P/E of 35.84, the stock trades below its industry multiple.
What to watch: A market cap of Rs 1,529 Cr means the share price can swing sharply.
Titan Biotech: Bioscience Ingredients Build the Next Leg
Titan Biotech’s roadmap rests on bioscience and speciality ingredient products, with new applications and exports supporting revenue.
Revenue grew from Rs 124.49 crore in FY22 to Rs 211.60 crore in FY26, a 70.0% rise, and FY26 revenue was 32.0% higher than FY25. FY26 net profit rose 50.2% to Rs 27.45 crore. Over four years, net profit rose from Rs 21.68 crore in FY22 to Rs 27.45 crore. In Q1 FY27, revenue grew 29.1% to Rs 60.98 crore, and net profit rose 53.6% to Rs 9.46 crore. Operating margin was 21.34% in FY26 and 24.17% in Q1 FY27 against 20.34% a year earlier.
Debt to equity is 0.03 and return on equity is 16.46%. FY26 operating cash flow was Rs 30.42 crore against capital expenditure of Rs 7.43 crore. Titan Biotech paid a dividend of Rs 0.5 per share for FY26, a yield of 0.13%. At a P/E of 46.60 against an industry P/E of 37.19, the stock trades above its industry multiple.
What to watch: FY25 net profit of Rs 18.27 Cr was lower than the Rs 23.66 Cr of FY24, and a market cap of Rs 1,579 Cr means the share price can swing sharply. The P/E of 46.60 sits above the industry P/E of 37.19, so earnings delivery matters for the valuation.
Best Aqua Feed and Bioscience Stocks in India: Avanti Feeds vs Nitta Gelatin vs Titan Biotech on Key Financials
Among the best aqua feed and bioscience stocks in India, Nitta Gelatin leads on FY26 operating margin and return on equity; Titan Biotech leads on Q1 FY27 revenue growth and five-year revenue growth. The table puts the numbers side by side.
| Metric | Avanti Feeds | Nitta Gelatin | Titan Biotech |
|---|---|---|---|
| FY26 revenue (Rs Cr) | 6,276.46 | 600.96 | 211.60 |
| FY26 revenue growth | 8.9% | 12.0% | 32.0% |
| Revenue growth FY22 to FY26 | 22.6% | 17.7% | 70.0% |
| FY26 net profit (Rs Cr) | 655.76 | 98.25 | 27.45 |
| FY26 net profit growth | 17.8% | 15.9% | 50.2% |
| FY26 operating profit margin | 15.64% | 25.20% | 21.34% |
| Q1 FY27 revenue growth (YoY) | 18.7% | 2.3% | 29.1% |
| Q1 FY27 net profit growth (YoY) | -37.4% | 31.6% | 53.6% |
| Return on equity | 18.44% | 19.02% | 16.46% |
| P/E ratio | 16.55 | 14.81 | 46.60 |
| Debt to equity | 0.00 | 0.01 | 0.03 |
| Dividend yield | 1.40% | 0.42% | 0.13% |
| FY26 operating cash flow (Rs Cr) | 504.63 | 122.49 | 30.42 |
Feed and ingredient earnings follow shrimp prices and export demand, so full-year numbers and quarterly trends together give a better view.
How to Evaluate Shrimp Feed and Gelatin Stocks to Buy Before You Invest
A short checklist keeps the research consistent when you screen aqua feed and bioscience stocks and shortlist shrimp feed and gelatin stocks to buy.
- Compare each stock’s P/E with its industry P/E, which differs by stock.
- Track operating margin across several quarters, because input costs can move faster than prices.
- Check whether revenue growth is turning into profit growth, not only sales.
- Read operating cash flow against capital expenditure to see how growth is funded.
- Watch debt to equity and interest cover before sizing a position.
- Spread exposure across companies and business lines instead of one demand cycle.
Check the Univest Screener for live data on these aqua feed and bioscience stocks
Risks to Consider Before Investing in Aqua Feed and Bioscience Stocks
- Shrimp prices and exports: Falling prices or trade barriers cut feed demand.
- Quarterly profit: Avanti Feeds’ Q1 FY27 net profit was 37.4% lower than a year earlier.
- Valuation: Titan Biotech trades at 46.60 times earnings against an industry multiple of 37.19.
- Small size: Nitta Gelatin and Titan Biotech have market caps near Rs 1,500 Cr, so shares can swing sharply.
Download the Univest iOS App or Univest Android App to track Avanti Feeds, Nitta Gelatin and Titan Biotech live.
Final Take: Which Stock Has the Strongest Roadmap?
These three shrimp feed and gelatin stocks cover shrimp feed and exports, gelatin and collagen peptides, and bioscience ingredients. Nitta Gelatin leads on FY26 operating margin and return on equity; Titan Biotech leads on Q1 FY27 revenue growth and five-year revenue growth.
Across feed and speciality ingredient stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the shrimp feed and gelatin stocks to buy discussed here.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Aqua Feed and Bioscience Stocks
Which are the best aqua feed and bioscience stocks in India with a strong roadmap?
Ans. Avanti Feeds, Nitta Gelatin India and Titan Biotech stand out for their roadmaps in shrimp feed, gelatin and bioscience ingredients. FY26 revenue growth was 8.9% at Avanti Feeds, 12.0% at Nitta Gelatin and 32.0% at Titan Biotech, and return on equity ranges from 16.46% to 19.02%.
Is Avanti Feeds a good stock to buy now?
Ans. Avanti Feeds has a debt to equity ratio of 0.00, a return on equity of 18.44% and a P/E of 16.55 against an industry P/E of 34.46. Shrimp prices, quarterly profit and valuation move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.
What is the P/E ratio of Avanti Feeds, Nitta Gelatin and Titan Biotech?
Ans. The P/E ratio is 16.55 for Avanti Feeds (industry 34.46), 14.81 for Nitta Gelatin (industry 35.84) and 46.60 for Titan Biotech (industry 37.19). Only Titan Biotech trades at or above the industry multiple.
Which of these aqua feed and bioscience stocks has the highest return on equity?
Ans. Nitta Gelatin India has the highest return on equity at 19.02%, followed by Avanti Feeds at 18.44% and Titan Biotech at 16.46%.
What are the risks of investing in aqua feed and bioscience stocks?
Ans. The main risks are shrimp price and export swings, lower quarterly profit at one firm, a premium valuation at another and small company size. Avanti Feeds’ Q1 FY27 net profit was 37.4% lower than a year earlier.
How did Avanti Feeds, Nitta Gelatin and Titan Biotech perform in Q1 FY27?
Ans. Avanti Feeds reported revenue of Rs 1,965.58 crore, up 18.7% year on year, and net profit fell 37.4% to Rs 116.31 crore. Nitta Gelatin India reported revenue of Rs 144.54 crore, up 2.3% year on year, and net profit rose 31.6% to Rs 25.18 crore. Titan Biotech reported revenue of Rs 60.98 crore, up 29.1% year on year, and net profit rose 53.6% to Rs 9.46 crore.
Do aqua feed and bioscience stocks pay dividends?
Ans. Yes, all three companies pay dividends. The dividend yield is 1.40% for Avanti Feeds, 0.42% for Nitta Gelatin and 0.13% for Titan Biotech, based on dividends declared for FY26.
How can I invest in aqua feed and bioscience stocks in India?
Ans. You can buy aqua feed and bioscience stocks through a demat and trading account on NSE or BSE after checking each company’s financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.